首页> 外文期刊>Renal failure. >Comparison of kidney paired donation transplantations with living related donor kidney transplantation: Implications for national kidney paired donation program
【24h】

Comparison of kidney paired donation transplantations with living related donor kidney transplantation: Implications for national kidney paired donation program

机译:肾脏配对捐赠与活体相关捐赠者肾脏移植的比较:对国家肾脏配对捐赠计划的启示

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Kidney Paired Donation (KPD) is a rapidly growing modality for facilitating living related donor kidney transplantation (LRDKTx) for patients who are incompatible with their healthy, willing, and living donors. Data scarcity on the outcome of KPD versus LRDKTx prompted us to review our experience. Materials and methods: This was a single-center study of 224 patients on regular follow-up, who underwent LRDRTx from January 2010 to June 2012 at our institute. The aim of this study was to compare short-term graft survival, patient survival and rejection rates of KPD (group 1, n = 34) with those of LRDKTx (group 2, n = 190). All the recipients received triple immunosuppression and thymoglobulin induction in KPD group. Kaplan-Meier curves were used for survival analysis. In group 1, mean recipient age was 35.5 ± 13.2 years, 29 were men and mean donor age was 44.4 ± 8.17 years, 10 were men. In group 2, mean recipient age was 29.1 ± 10 years, 155 were men and mean donor age was 47.5 ± 9.69 years, 74 were men. Mean human leukocyte antigen (HLA) matching in group 1 and 2 was 1 versus 3.2 (p < 0.05). Results: One- and two-year patient survival showed no significant difference between the two groups (97.1%, 97.1% vs. 96.2%, 94.8%, respectively, p = 0.81). Death-censored graft survival also showed no significant difference between the two groups (97.1%, 97.1%, vs. 97.6%, 97.6%, p = 0.73). Acute rejection incidence was also similar (8.7% vs. 9.9%, p > 0.62). Conclusions: Our study showed similar graft survival, patient survival and rejection rates of KPD versus LRDKTx over 2 years post-transplantation, encouraging the use of this approach for national KPD program. Copyrigh
机译:背景:肾脏配对捐赠(KPD)是一种快速发展的模式,用于为与健康,愿意和活体供体不匹配的患者提供与生活相关的供体肾移植(LRDKTx)。关于KPD与LRDKTx结局的数据稀缺性促使我们回顾我们的经验。材料和方法:这是一项针对224名定期随访患者的单中心研究,这些患者于2010年1月至2012年6月在我院接受了LRDRTx治疗。这项研究的目的是比较KPD(第1组,n = 34)和LRDKTx(第2组,n = 190)的短期移植物存活率,患者存活率和排斥率。 KPD组所有接受者均接受三重免疫抑制和胸腺球蛋白诱导。 Kaplan-Meier曲线用于生存分析。第一组中,平均接受者年龄为35.5±13.2岁,男性为2​​9岁,平均供体年龄为44.4±8.17岁,男性为10岁。在第二组中,平均接受者年龄为29.1±10岁,男性为155岁,平均供体年龄为47.5±9.69岁,男性为74岁。第1组和第2组的平均人白细胞抗原(HLA)匹配为1对3.2(p <0.05)。结果:两组患者的一年和两年生存率无显着差异(分别为97.1%,97.1%和96.2%,94.8%,p = 0.81)。死亡检查的移植物存活率在两组之间也没有显着差异(97.1%,97.1%,而97.6%,97.6%,p = 0.73)。急性排斥反应发生率也相似(8.7%vs. 9.9%,p> 0.62)。结论:我们的研究表明,在移植后的2年中,KPD与LRDKTx相比,KPD的移植物存活率,患者存活率和排斥率相似,这鼓励该方法用于国家KPD计划。版权

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号